Cor Clinical Research, Llc

Oklahoma City, Oklahoma 73107

0 studies enrolling now · 37 studies all time

What they study most

Acute Coronary Syndrome, Albuminuria, Atherosclerosis, Atrial Fibrillation, Atrial Flutter, Back Pain Lower Back Chronic, Cardiovascular Disease, Chronic Bronchitis, Chronic Idiopathic Constipation, Chronic Obstructive Pulmonary Disease, Coronary Artery Disease, Diabetes Mellitus, Type 1

Studies at this site

• Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension — Completed
• Study to Evaluate the Efficacy and Safety of K-877 in Adult Patients With Fasting High Triglyceride Levels and Mild or Moderate Renal Impairment — Completed
• A Study for Patients With Neurogenic Orthostatic Hypotension — Completed
• Tanezumab in Osteoarthritis of the Hip or Knee (2) — Completed
• Extension Study Of Tanezumab In Osteoarthritis — Stopped early
• Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain — Completed
• Cardiovascular Inflammation Reduction Trial — Completed
• A Study of LY2623091 in Participants With High Blood Pressure — Completed
• A Phase 3 Study of Tanezumab for Chronic Low Back Pain — Completed
• Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL) — Completed
• Opioid-induced Bowel Dysfunction: Long-Term Assessment of Lubiprostone — Completed
• A Study of LY2951742 in Participants With Migraine — Completed
• A Safety and Efficacy Study of AGN-214868 in Patients With Postherpetic Neuralgia — Stopped early
• Opioid-induced Bowel Dysfunction: Pivotal Assessment of Lubiprostone — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA) — Completed
• Empagliflozin as Adjunctive to Insulin Therapy Over 26 Weeks in Patients With T1DM (EASE-3) — Completed
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation — Completed
• Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM — Completed
• Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment — Completed
• Phase III Acute Coronary Syndrome — Stopped early
• A Multicenter, Double-Blind, Randomized, Placebo-Controlled, 12-Week, Dose-Range-Finding Trial of YKP10811 Capsules Administered Once Daily to Subjects With Chronic Idiopathic Constipation — Completed
• Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) — Completed
• Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) — Completed
• Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed
• Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Low Back Pain — Stopped early
• Buprenorphine Transdermal Patches (BTDS) in Subjects With Osteoarthritis Pain. Includes a 52-week Extension Phase. — Stopped early
• Safety of BTDS in Subjects With Low Back Pain: A 52-Week Extension Phase of BUP3015 — Stopped early
• Determine the Safety and Efficacy of (R,R)-Formoterol in the Treatment of Subjects With COPD — Completed
• To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPD — Completed
• A Study To Evaluate The Dose-Related Efficacy and Safety of PS433540 in Subjects With Hypertension — Completed
• A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia — Completed
• Study of XL784 in Patients With Albuminuria Due to Diabetic Nephropathy — Completed
• Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes — Completed
• Safety and Efficacy Study of PN2034 in Type 2 Diabetes Patients on Concomitant Rosiglitazone and Metformin (or Avandamet) — Completed
• ARISE - Aggressive Reduction of Inflammation Stops Events — Status unconfirmed